Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Endocrinol.

Sec. Bone Research

Novel aspects of biochemical assessment of bone remodeling and mineralization

Provisionally accepted
Dorota  LeszczyńskaDorota Leszczyńska1Alicja  SzatkoAlicja Szatko1,2,3*Agata  TobołaAgata Toboła1Katarzyna  KarońKatarzyna Karoń1Waldemar  MisiorowskiWaldemar Misiorowski1Piotr  GlinickiPiotr Glinicki1,2Wojciech  ZgliczyńskiWojciech Zgliczyński1
  • 1Department of Endocrinology, Centre of Postgraduate Medical Education, Warsaw, Poland
  • 2EndoLab Laboratory, Centre of Postgraduate Medical Education, Warsaw, Poland
  • 3Doctoral School of Translational Medicine, Centre of Postgraduate Medical Education, Warsaw, Poland

The final, formatted version of the article will be published soon.

The maintenance of skeletal integrity relies on bone remodeling, a dynamic process orchestrated by the interplay between osteoclasts, osteoblasts, and the regulatory network of osteocytes. Traditional bone turnover markers (BTM) provide a non-invasive tool to assess bone metabolic activity. However, their clinical utility is limited by a low specificity and poor reproducibility. Moreover, traditional BTM do not reflect osteocyte function, despite the central role of these cells in bone remodeling. Novel BTM, including proteins (namely sclerostin, DKK-1, RANKL/OPG, and periostin), lipids (namely sphingosine-1-phosphate), and miRNAs, offer more specific insights into the interactions between bone cells and molecular signaling within the bone microenvironment. These markers represent potential therapeutic targets, with anti-sclerostin antibodies already approved for osteoporosis treatment. Another fundamental aspect of skeletal integrity is the process of mineralization, which is tightly regulated by three hormones: parathyroid hormone (PTH), vitamin D, and fibroblast growth factor 23 (FGF-23). These hormones not only maintain systemic calcium-phosphate homeostasis but also exert direct effects on bone cells, thereby influencing bone remodeling. This narrative review summarizes the functions, commonly used analytical methods, and clinical applications of novel BTM. It also presents the mechanisms of action of these hormones on bone tissue, along with new analytical approaches for measuring vitamin D, PTH, and FGF-23. The application of "omics" techniques in bone remodeling assessment is also discussed, with an emphasis on the advantages and limitations of these approaches.

Keywords: Bone Remodeling, Bone turnover biomarkers, bone mineralization, Immunoassay, RANK Ligand, Parathyroid Hormone, Vitamin D

Received: 09 Sep 2025; Accepted: 31 Oct 2025.

Copyright: © 2025 Leszczyńska, Szatko, Toboła, Karoń, Misiorowski, Glinicki and Zgliczyński. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Alicja Szatko, alicja.szatko@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.